Doo Young Jung

Company: Pinotbio

Job title: Chief Executive Officer

Seminars:

2:30pm Evaluating Efficacy & Safety of Dual-Payload ADCs in Preclinical Models to Establish Their Value Over SinglePayload Alternatives 2:30 pm

Discussing the unique challenges of demonstrating efficacy for dual-payload ADCs compared to single-payload ADCs, which often achieve complete regression in preclinical studies Exploring experimental designs to assess the added therapeutic potential of dual-payload ADCs in tumor models Identifying the approach to accurately predicting ADME properties of dual-payload ADCsRead more

day: Day One Preclinical & Clinical Development Track

11:00am Navigating Linker, Payload & Conjugation Site Selection 11:00 am

Optimize your ADC development by understanding how linker chemistry, payload selection, and conjugation sites influence efficacy and safety. This session will provide a structured approach to evaluating payload choices and refining ADC design for improved therapeutic outcomes Evaluating payload choices for ADCs Reviewing linker design chemistry considerations Understanding the impact of conjugation site selection on…Read more

day: Introduction to ADCs Seminar Day